A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
Public ClinicalTrials.gov record NCT04554914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Single-arm, Multicohort, Phase 2 Study to Assess the Efficacy and Safety of Tabelecleucel in Subjects With Epstein Barr Virus Associated Diseases (EBVision)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.
Study identification
- NCT ID
- NCT04554914
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 190 participants
Conditions and interventions
Conditions
- Epstein-Barr Virus (EBV)-Associated Diseases
- EBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)
- EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)
- EBV+ Posttransplant Lymphoproliferative Disease in Central Nervous System (EBV+ CNS PTLD)
- EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD)
- Solid Organ Transplant Complications
- Lymphoproliferative Disorders
- Allogeneic Hematopoietic Cell Transplant
- Stem Cell Transplant Complications
- EBV+ Sarcomas
- Leiomyosarcoma
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 14, 2021 (Actual)
- Primary completion
- Jun 2027 (Estimated)
- Completion
- May 2028 (Estimated)
- Last update posted
- Jul 31, 2026
2021 – 2028
United States locations
- U.S. sites
- 23
- U.S. states
- 14
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California Los Angeles (UCLA) (Adults and Pediatrics) | Los Angeles | California | 90095 | — |
| Children's Hospital of Orange County (Pediatrics [up to 25 years old]) | Orange | California | 92868 | — |
| Lucile Packard Children's Hospital Stanford (Pediatrics only) | Palo Alto | California | 94304 | — |
| University of California Davis Comprehensive Cancer Center (Adults and Pediatrics) | Sacramento | California | 95817 | — |
| Sylvester Comprehensive Cancer Center/ University of Miami | Miami | Florida | 33136 | — |
| Moffit Cancer Center (Adults only) | Tampa | Florida | 33612 | — |
| Children's Healthcare of Atlanta (Pediatrics only [up to 25 years old]) | Atlanta | Georgia | 30322 | — |
| Emory University/Winship Cancer Institute (Adults [>= 16 years]) | Atlanta | Georgia | 30322 | — |
| Ann & Robert H. Lurie Children's Hospital of Chicago (Pediatrics only) | Chicago | Illinois | 60611 | — |
| University of Maryland Medical Center (Adults only) | Baltimore | Maryland | 21201 | — |
| Dana Farber Cancer Institute (DFCI) (Adults and Pediatrics) | Boston | Massachusetts | 02215 | — |
| University of Michigan Rogel Cancer Center (Adults and Pediatrics) | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota (Adults only) | Minneapolis | Minnesota | 55455 | — |
| Washington University in St. Louis (Adults only) | St Louis | Missouri | 63108 | — |
| Columbia University Irving Medical Center (Adults only) | New York | New York | 10032 | — |
| Memorial Sloan-Kettering Cancer Center (Adults and Pediatrics) | New York | New York | 10065 | — |
| The Children's Hospital at Montefiore (Adults and Pediatrics) | The Bronx | New York | 10467 | — |
| Cleveland Clinic Taussig Cancer Center (Adults and Pediatrics) | Cleveland | Ohio | 44195 | — |
| The Ohio State University - The James Cancer Hospital and Solove Research Institute (Adults only) | Columbus | Ohio | 43210 | — |
| Oregon Health and Science University (Adults and Pediatrics) | Portland | Oregon | 97239 | — |
| Medical University of South Carolina (Adults and Pediatrics) | Charleston | South Carolina | 29425 | — |
| University of Texas Southwestern Medical Center (Pediatrics only) | Dallas | Texas | 75390 | — |
| MD Anderson (Adults and Pediatrics) | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04554914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2026 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04554914 live on ClinicalTrials.gov.